Endo Inc NDOI
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
Endo Presents Data at the American Orthopaedic Foot & Ankle Society Annual Meeting
-
ENDO ANNOUNCES CEO TRANSITION
-
ENDO REPORTS SECOND-QUARTER 2024 FINANCIAL RESULTS
-
Endo to Host Investor Call on Second Quarter 2024 Financial Results
-
Endo Announces Effectiveness of Form S-1 Registration Statement for Existing Shares
-
Endo USA, Inc. Issues Voluntary, Nationwide Recall of One Lot of Clonazepam Orally Disintegrating Tablets, USP (C-IV) Lot Number 550147301 Due to Mislabeling: Incorrect Strength on Product Carton
-
Endo Launches Tiopronin Delayed-Release Tablets, Generic Version of THIOLA EC®
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- —–—
- Bid/Ask
- — / —
- Market Cap
- —
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Endo Inc is a diversified specialty pharmaceutical company that develops, manufactures, markets and sells a broad portfolio of pharmaceutical products across four reportable segments: Branded Pharmaceuticals, Sterile Injectables, Generic Pharmaceuticals and International Pharmaceuticals.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- —
- Total Number of Employees
- —
- Website
- https://www.endo.com
Comparables
Valuation
|
Metric
|
NDOI
|
000739
|
600216
|
|---|---|---|---|
Price/Earnings (Normalized) | — | 20.02 | 68.87 |
Price/Book Value | — | 3.18 | 1.67 |
Price/Sales | — | 1.69 | 1.98 |
Price/Cash Flow | — | 10.59 | 16.04 |
Price/Earnings
NDOI
000739
600216
Financial Strength
|
Metric
|
NDOI
|
000739
|
600216
|
|---|---|---|---|
Quick Ratio | — | 0.97 | 1.68 |
Current Ratio | — | 1.30 | 2.66 |
Interest Coverage | — | 35.39 | 15.43 |
Quick Ratio
NDOI
000739
600216
Profitability
|
Metric
|
NDOI
|
000739
|
600216
|
|---|---|---|---|
Return on Assets (Normalized) | — | 7.96% | 1.81% |
Return on Equity (Normalized) | — | 16.93% | 2.37% |
Return on Invested Capital (Normalized) | — | 13.55% | 2.20% |
Return on Assets
NDOI
000739
600216
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Zoetis Inc Class A
ZTS
| Mhgbqxztp | Nswq | $87.2 Bil | |||
| Merck KGaA ADR
MKKGY
| Qkgkfybpcf | Gywxpzp | $75.7 Bil | |||
| Haleon PLC ADR
HLN
| Ydtwjyfg | Hvpq | $47.3 Bil | |||
| Teva Pharmaceutical Industries Ltd ADR
TEVA
| Ctqnxczvm | Hxnc | $20.0 Bil | |||
| Viatris Inc
VTRS
| Phjvmqgh | Pcld | $13.7 Bil | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| Glvygcfss | Lfzh | $13.4 Bil | |||
| Catalent Inc
CTLT
| Zcsckbg | Ddjzn | $11.0 Bil | |||
| Prestige Consumer Healthcare Inc
PBH
| Lhmybmchf | Zwcfklq | $3.5 Bil | |||
| Perrigo Co PLC
PRGO
| Tcflcvhk | Ldrv | $3.4 Bil | |||
| Green Thumb Industries Inc
GTBIF
| Pgmgkldx | Ztlz | $2.4 Bil |
United States